Design Therapeutics, Inc. (DSGN)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
15. 14
+0.05
+0.3313%
After Hours
$
+0.63 +4.1612% 15. 77
942.48M Market Cap
- P/E Ratio
- Div Yield
476,963 Volume
-1.18 Eps
$ 15.09
Previous Close 
Want to track DSGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Design Therapeutics, Inc. (DSGN) Statistics
Valuation metrics
Market Cap 942.48M
Enterprise value 932.85M
Trailing P/E (ttm) -12.81
Forward P/E -
PEG ratio 2.3
Price/Sales (ttm) -
Price/Book (mrq) 4.68
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 820.75K
Average volume (90 days) 816.54K
Price summary
52-Week low 5.28
52-Week high 17.25
Beta -
50-Day moving average 13.5
200-Day moving average 11.91
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.33%
Return on equity -0.34%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.32
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 18.86%
Book value per share (mrq) 3.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
